Pacific Biosciences Of California PACB
NASDAQ PACB
$1.29 +0.02 (+1.73%)
At close: Aug 20, 2026 · 11:12 AM UTC

Pacific Biosciences Of California (PACB) EPS (Diluted) (2014 - 2026)

Pacific Biosciences Of California (PACB) EPS (Diluted) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Abbott Laboratories 200.08 Bn 194.48 Bn 7.27 Bn 0.53
2 Stryker 129.71 Bn 126.23 Bn 4.50 Bn 3.31
3 Medtronic 120.07 Bn 110.85 Bn 6.41 Bn 0.98
4 Boston Scientific 74.08 Bn 73.54 Bn 3.85 Bn 0.61
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 0.42
6 Dexcom 34.51 Bn 32.56 Bn 830.00 Mn 0.64
7 GE HealthCare Technologies 34.03 Bn 31.92 Bn 2.18 Bn 1.26
8 Koninklijke Philips 26.51 Bn 23.19 Bn 4.55 Bn 0.64
9 Steris 23.20 Bn 22.72 Bn 684.20 Mn 2.05
10 Pacific Biosciences Of California 400.74 Mn 163.87 Mn 12.64 Mn -0.14

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.14
Mar 31, 2026 -0.03
Dec 31, 2025 -0.13
Sep 30, 2025 -0.13
Jun 30, 2025 -0.14
Mar 31, 2025 -1.44
Dec 31, 2024 0.01
Sep 30, 2024 -0.22
Jun 30, 2024 -0.64
Mar 31, 2024 -0.29
Dec 31, 2023 -0.32
Sep 30, 2023 -0.26
Jun 30, 2023 -0.28
Mar 31, 2023 -0.36
Dec 31, 2022 -0.38
Sep 30, 2022 -0.34
Jun 30, 2022 -0.32
Mar 31, 2022 -0.37
Dec 31, 2021 -0.34
Jun 30, 2021 -0.44